Hydrogen: Clinical Trials

23 trials of Hydrogen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 5 recruiting, 4 unknown, 2 not yet recruiting. 9 Not applicable, 6 Phase 2, 5 Phase 1, 4 Phase 3, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 4, Not yet recruiting 2, Recruiting 2, Unknown 1
Phase 26Recruiting 2, Active not recruiting 1, Completed 1, Terminated 1, Unknown 1
Phase 15Completed 2, Unknown 2, Recruiting 1
Phase 34Completed 3, Terminated 1
Early Phase 11Completed 1

Follow Hydrogen: new trials by email Literature Review of Hydrogen trials Research Report on Hydrogen

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Controlled Trial of Hydrogen Water as a Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Placebo condition, Molecular hydrogen produced by a metallic magnesium tablet, consumed 3x a day dissolved in water. Treatment duration is 16 weeks. - Chronic Fatigue Syndrome (CFS)
Not applicableRecruitingFred Friedberg802026-08-152026-08-07
Effect of Pre-exercise Inhalation of Molecular Hydrogen on Metabolic Response During Graded Exercise in Healthy Women
Molecular hydrogen, Placebo - Healthy Adult Females
Not applicableRecruitingPalacky University222026-06-222026-06-25
Molecular Hydrogen Inhalation: Effects on Health, Exercise Capacity and Inflammatory Response - in Vivo/in Vitro Studies
Inhalation using a molecular hydrogen generator - Physiological Adaptations, Sport Performance
Not applicableNot yet recruitingGdansk University of Physical Education and Sport2502025-10-012025-08-19
Hydrogen-Rich Water and Resting Metabolism in Young Adults
Molecular Hydrogen, Placebo Comparator - Healthy Subjects or Volunteers
Not applicableNot yet recruitingUniversity of Novi Sad242025-09-012025-08-01
Effect of Molecular Hydrogen Inhalation on Metabolic Response During Low-intensity Exercise on a Bicycle Ergometer
Molecular hydrogen, Placebo - Healthy, Respiratory Quotient Measurement
Not applicableCompletedPalacky University202025-05-052026-06-25
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Hydrogen capsules - Chronic Disease, Chronic Inflammation
Phase 2UnknownHoHo Biotech602024-05-112024-05-07
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Hydrogen, Usual care - Cardiac Arrest, Extracorporeal Membrane Oxygenation
Phase 1RecruitingBoston Children's Hospital532024-03-042025-07-03
Effect of Inhaled Molecular Hydrogen on Recovery Process After Downhill Walking on the Treadmill
Molecular hydrogen, Placebo - Muscle Soreness, Muscle Fatigue
Not applicableCompletedPalacky University142023-08-142023-12-01
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
Hydrogen tablets, Control - Mucositis Oral
Early Phase 1CompletedStony Brook University242022-05-252025-05-14
To Evaluate the Safety of Treating Rheumatologic and Metabolic Patients With Molecular Hydrogen Supplement.
Hydrogen - Autoimmune Diseases, Metabolic Disease
Phase 1UnknownHoHo Biotech302022-01-112022-02-10
To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
Hydrogen - Autoimmune Diseases
Phase 1UnknownHoHo Biotech272021-08-132021-11-10
Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care
MOLECULAR HYDROGEN, PLACEBO MAGNESIUM - SARS-CoV-2, Covid19
Not applicableUnknownAGIR à Dom7002021-01-222022-04-05
Safety of Inhaled Hydrogen Gas Mixtures in Healthy Volunteers
Hydrogen - Healthy
Phase 1CompletedBoston Children's Hospital82020-10-262021-05-06
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas.
Hydrogen, Placebo oral tablet - Malignant Glioma
Phase 2Active not recruitingStony Brook University152019-10-312025-07-29
Clinical Trial to Evaluate the Safety and Tolerability of Hydrogen in Patients With Parkinson's Disease
Hydrogen, Placebo oral tablet - Parkinson Disease
Phase 2 / Phase 3TerminatedStony Brook University22019-05-292023-04-12
Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease
Hydrogen, Placebo - Non-Alcoholic Fatty Liver Disease
Not applicableCompletedUniversity of Novi Sad, Faculty of Sport and Physical Education102018-09-012019-04-16
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance
Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Spectroscopic Imaging, MRI Ultrasound Fusion Guided Biopsy - Prostate Adenocarcinoma, Prostate Cancer
Phase 2RecruitingUniversity of California, San Francisco602018-07-182026-05-18
Hydrogen Inhalation for Health and Exercise Performance
Placebo, Hydrogen - Exercise Performance
Not applicableCompletedUniversity of Novi Sad, Faculty of Sport and Physical Education202018-01-152019-02-20
Neuroprotection in Acute Ischemic Stroke
Hydrogen, Minocycline, Placebo Hydrogen - Stroke, Ischemic
Phase 2 / Phase 3CompletedStony Brook University152017-08-022023-12-19
Molecular Hydrogen for Cognitive Function and Performance in Elderly
Molecular Hydrogen - Cognitive Impairments, Aging
Phase 3CompletedUniversity of Novi Sad, Faculty of Sport and Physical Education132016-07-012016-10-28

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Autoimmune Diseases (2)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  COVID-19 (1)  ·  Chronic Disease (1)  ·  Cognitive Dysfunction (1)  ·  Fatigue Syndrome, Chronic (1)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Heart Arrest (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Ischemic Stroke (1)  ·  Metabolic Diseases (1)  ·  Myalgia (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Sponsors

Stony Brook University (4)  ·  HoHo Biotech (3)  ·  Palacky University (3)  ·  University of Novi Sad, Faculty of Sport and Physical Education (3)  ·  Boston Children's Hospital (2)  ·  AGIR à Dom (1)  ·  Center for Health Sciences, Serbia (1)  ·  Fred Friedberg (1)  ·  Gdansk University of Physical Education and Sport (1)  ·  GlaxoSmithKline (1)  ·  Navy General Hospital, Beijing (1)  ·  University of California, San Francisco (1)  ·  University of Novi Sad (1)

Countries

United States (8)  ·  Serbia (5)  ·  Czechia (3)  ·  Taiwan (3)  ·  China (1)  ·  France (1)  ·  India (1)  ·  Morocco (1)  ·  Poland (1)

Top investigators

Adam Jarmar, Mgr (1)  ·  Agnieszka Kowalska, MD (1)  ·  Carine Maurer, MD,PhD (1)  ·  Dennis Choi, MD, PhD (1)  ·  Fred Friedberg, PhD (1)  ·  Ivan de Kouchkovsky, MD (1)  ·  John Kheir, MD (1)  ·  John N Kheir, MD (1)  ·  Kartik Mani, MD (1)  ·  Liren Qian, M.D. (1)  ·  Sergej Ostojic, MD, PhD (1)  ·  Tereza Rysava (1)  ·  Yoann Gaboreau, Dr (1)

Results publications

PMID 28560519, PMID 30982748, PMID 31061920, PMID 31938004, PMID 33324415, PMID 37521410, PMID 41204320

NIH funding

R01CA211150 (1), R01CA300053 (1), R01EB017449 (1), U01CA232320 (1)